UK stroke campaign results suggest clear market push-pull impact
This article was originally published in Clinica
A campaign to raise awareness in the UK of the symptoms of stroke and the importance of rapid medical intervention has resulted in a 70% rise in the number of stroke-related calls to the emergency services, the Department of Health (DH) announced today. The news provides an insight into the type of push-pull impact that public awareness can have on key medtech sectors. The campaign, launched in February, sought to address one of the aims of the national stroke plan, which also features better access to diagnostic imaging and therapeutic interventions.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.